Halda Therapeutics

News

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy Halda Therapeutics and its RIPTAC anticancer platform.

News

Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.